BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20713471)

  • 1. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
    Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
    Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells.
    Maeshima H; Ohno K; Tanaka-Azuma Y; Nakano S; Yamada T
    Toxicol In Vitro; 2009 Feb; 23(1):148-57. PubMed ID: 19000923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures.
    Mascolo MG; Perdichizzi S; Rotondo F; Morandi E; Guerrini A; Silingardi P; Vaccari M; Grilli S; Colacci A
    Toxicol In Vitro; 2010 Jun; 24(4):1292-300. PubMed ID: 20226850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
    Thomas RS; Pluta L; Yang L; Halsey TA
    Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalidation study of the BALB/c 3T3 cell transformation assay for assessment of carcinogenic potential of chemicals.
    Tanaka N; Bohnenberger S; Kunkelmann T; Munaro B; Ponti J; Poth A; Sabbioni E; Sakai A; Salovaara S; Sasaki K; Thomas BC; Umeda M
    Mutat Res; 2012 Apr; 744(1):20-9. PubMed ID: 22198331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Balb/c 3T3 cell transformation assay and its application to the screening of carcinogens].
    Zhang L; Zeng Y
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):226-32. PubMed ID: 19408670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells).
    Asada S; Sasaki K; Tanaka N; Takeda K; Hayashi M; Umeda M
    Mutat Res; 2005 Dec; 588(1):7-21. PubMed ID: 16260176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bhas 42 cell transformation assay on 98 chemicals: the characteristics and performance for the prediction of chemical carcinogenicity.
    Sakai A; Sasaki K; Muramatsu D; Arai S; Endou N; Kuroda S; Hayashi K; Lim YM; Yamazaki S; Umeda M; Tanaka N
    Mutat Res; 2010 Sep; 702(1):100-22. PubMed ID: 20656056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
    Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
    Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
    Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
    Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
    Waters MD; Jackson M; Lea I
    Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
    van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
    Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an in vitro screening test for predicting the tumor promoting potential of chemicals based on gene expression.
    Maeshima H; Ohno K; Nakano S; Yamada T
    Toxicol In Vitro; 2010 Apr; 24(3):995-1001. PubMed ID: 20025956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of human cell models for assessing the carcinogenic potential of chemicals.
    Pang Y; Li W; Ma R; Ji W; Wang Q; Li D; Xiao Y; Wei Q; Lai Y; Yang P; Chen L; Tang S; Lin Y; Zhuang Z; Zheng Y; Chen W
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):478-86. PubMed ID: 18778725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international validation study of a Bhas 42 cell transformation assay for the prediction of chemical carcinogenicity.
    Sakai A; Sasaki K; Hayashi K; Muramatsu D; Arai S; Endou N; Kuroda S; Poth A; Bohnenberger S; Kunkelmann T; Asakura M; Hirose H; Ishii N; Mizuhashi F; Kasamoto S; Nagai M; Pant K; Bruce SW; Sly JE; Yamazaki S; Umeda M; Tanaka N
    Mutat Res; 2011 Oct; 725(1-2):57-77. PubMed ID: 21801851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
    Liu Z; Kelly R; Fang H; Ding D; Tong W
    Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.